1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Niacin (nicotinic acid, vitamin B3) |
| brand | String | Niaspan (ER, Rx), Niacor (IR, Rx); huge OTC presence |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Lipid-lowering_agents|Lipid-lowering agent]] • [[:Category:B-vitamins|B-vitamin]] • [[:Category:Vitamins|Vitamin]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00001035-QINU`"', '"`UNIQ--vote-00001036-QINU`"', '"`UNIQ--vote-00001037-QINU`"' |
| starting_dose | String | Niaspan ER 500 mg PO at bedtime, titrate weekly to 1-2 g/d; flushing-protective aspirin 30-60 minutes before dose; pellagra replacement 100-500 mg/d |
| preparations | String | OTC IR niacin 50-500 mg tablets; Niaspan ER 500, 750, 1000 mg tablets; "no-flush" niacin (inositol hexaniacinate, lacks evidence) |
| fda_max | String | 2 g/d (Niaspan); higher off-label use historical |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | Lipid changes 4-8 weeks |
| duration | String | 24 hours |
| halflife | String | ~1 hour (IR niacin); ER formulations extend functional duration'"`UNIQ--ref-00001038-QINU`"' |
| bioavailability | String | High (oral; food enhances)'"`UNIQ--ref-00001039-QINU`"' |
| pregnancy | String | Pharmacologic doses generally avoided in pregnancy; vitamin doses fine.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | OTC (low-dose, dietary supplement) and [[USLegal:Prescription only|Rx-only]] (Niaspan ER) in US |
